Galantamine in the Treatment of Post-Traumatic Headache

Last updated: September 13, 2005
Sponsor: Rapoport, Alan, M.D.
Overall Status: Trial Status Unknown

Phase

4

Condition

Migraine (Pediatric)

Brain Injury

Pain (Pediatric)

Treatment

N/A

Clinical Study ID

NCT00219869
GAL-EMR-4006
  • Ages 18-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Most patients with CPTH present with additional major cognitive, behavioral and somatic problems. Most drugs used currently have a negative influence on cognition. Therefore, treatment strategies addressing both the headache and cognitive disturbances in patients with CPTH are necessary. (CPTH; Chronic Post Traumatic Headache).

Eligibility Criteria

Inclusion

Inclusion Criteria: Age range 18-75 CPTH according to ICHD-2 Fertile woman using adequate birth control Willingand able to give informed consent Willing and able to complete the entire course of thestudy to comply with study instructions Stable does of preventive medication

Exclusion

Exclusion Criteria: Subject is pregnant or lactating Significant medical or psychiatric disease Previousfailure to 4 or more adequate trials of preventive medication Patient on non-stable dose ofmedication used to prevent CPTH

Study Design

Total Participants: 30
Study Start date:
July 01, 2005
Estimated Completion Date:
August 31, 2005

Study Description

Headache is the most common symptom after a closed head injury, persisting for more then 2 months in 60% of the patients. CPTH is an important cause of consultations in neurology offices and headache clinics, posing a severe burden and affecting the quality of life of sufferers.

Connect with a study center

  • The New England Center for Headache

    Stamford, Connecticut 06902
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.